Dr Nicholas Draeger

Nicholas DraegerInvestment Director
BSc (Hons) PhD MBA

Nicholas started his career at Roche in the field of Alzheimer’s research and later was part of the Global Business Development team, specialising in M&A and licensing. At Recordati, he was Director of International Business Development.

Later, Nicholas headed the Biotech sell-side research group at the French finance group, Credit Agricole Indosuez Cheuvreux, and was scientific advisor for the healthcare research team. Nicholas was  a member of the management team of BB Biotech and later at Adamant Biomedical Investments both in Switzerland, where he specialised in investments in Asia, Australia and South Africa, as well as venture capital on a global basis.

Nicholas was a Senior Research Scientist in health economics at the University Hospital Basel, Switzerland. Nicholas is also a Founder and Managing Director of Cederberg Advisors GmbH in Switzerland; and Founder and Director of Algae Biotechnology Products Limited in the UK. Nicholas is currently an advisor to the government-sponsored Innovation Fund in South Africa.

Nicholas holds a Bsc (Hons) in Chemical Engineering from the University of Natal, Durban, South Africa, a PhD from the University of Cambridge, UK, in Biochemical Engineering, and a MBA from the University of Warwick, UK.